VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial

Published:2023-08 Issue: Volume:182 Page:107287
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Levallet Guénaëlle^ORCID,Dubois Fatéméh,Elie Nicolas,Creveuil Christian,Brosseau Solenn,Danel Claire,Scherpereel Arnaud,Lantuejoul Sylvie,Mazières Julien,Greillier Laurent,Audigier-Valette Clarisse,Bergot Emmanuel,Moro-Sibilot Denis,Molinier Olivier,Léna Hervé,Monnet Isabelle,Morin Franck,Gounant Valérie,Zalcman Gérard

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Molecular alterations in malignant pleural mesothelioma: a hope for effective treatment by targeting YAP;Dubois;Target. Oncol.,2022

2. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression;Kumar-Singh;J. Pathol.,1999

3. Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma avastin cisplatin pemetrexed study (MAPS): a randomised, controlled, open-label, phase 3 trial;Zalcman;Lancet,2016

4. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours;Ohta;Br. J. Cancer,1999

5. A review of bevacizumab in the treatment of malignant pleural mesothelioma;Brosseau;Future Oncol.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP